---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-090983"
form_type: "8-K"
ticker: "ADPT"
cik: "0001478320"
company_name: "Adaptive Biotechnologies Corp"
filed_at: "2024-04-09T23:59:59+00:00"
generated_at: "2026-06-04T00:53:53.442262+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Adaptive Biotechnologies appoints Kyle Piskel as CFO effective April 8, 2024

## Summary
- Kyle Piskel promoted from Principal Accounting Officer to CFO; reports to CEO Chad Robins.
- Base salary set at $380,000 per year; target bonus of 40% of eligible earnings.
- Receives RSU grant of 31,260 shares (4-year vesting) and PSU grant of 75,000 shares (3-year performance period).
- Also entitled to annual equity refresh of 43,740 RSUs, bringing 2024 total equity grants to 150,000 shares.

## SEC filing metadata
- accession: 0001193125-24-090983
- form_type: 8-K
- ticker: ADPT
- cik: 0001478320
- company_name: Adaptive Biotechnologies Corp
- filed_at: 2024-04-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1478320/000119312524090983/0001193125-24-090983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1478320/000119312524090983/d814314d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-090983
- JSON: https://secwatch.observer/filing/0001193125-24-090983.json
- Plain text: https://secwatch.observer/filing/0001193125-24-090983.txt

## Key facts
- Executive change
  Kyle Piskel was appointed as Chief Financial Officer at Adaptive Biotechnologies Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: As previously announced, Adaptive Biotechnologies Corporation (the “ Company ”) appointed Kyle Piskel, the Company’s Principal Accounting Officer, to serve as its Chief Financial Officer effective April 8, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1478320/000119312524090983/0001193125-24-090983-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.